Macrogenics reported $0 in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Abbvie ABBV:US $ 73474M 3210M
Amgen AMGN:US $ 36854M 3545M
AstraZeneca AZN:LN 31099M 318M
Biogen BIIB:US $ 7275.2M 2.1M
Bristol Myers Squibb BMY:US $ 44972M 419M
Cerulean Pharma CERU:US $ 0M 0M
Daiichi Sankyo 4568:JP Y 163461M 93M
Eli Lilly And LLY:US $ 16508.8M 375.9M
Epizyme EPZM:US $ 232.49M 0.38M
Genmab GEN:DC DK 416M 9M
Geron GERN:US $ 50.18M 0.35M
Gilead Sciences GILD:US $ 26208M 487M
Immunogen IMGN:US $ 0M 0M
Johnson & Johnson JNJ:US $ 33148M 603M
Karyopharm Therapeutics KPTI:US $ 302.49M 198K
Macrogenics MGNX:US $ 0M 0M
Merk MRK:US $ 31794M 1308M
Mirati Therapeutics MRTX:US $ 0M 0M
Pfizer PFE:US $ 36301M 2135M
Puma Biotechnology PBYI:US $ 97.38M 0.29M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 0.7M
Seattle Genetics SGEN:US $ 0M 0M
Xencor XNCR:US $ 0M 0M